The risk for opportunistic infections in inflammatory bowel disease with biologics: an update

Long-term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experience

(2018) P. Wils et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Biologic-Induced Infections in Inflammatory Bowel Disease: The TNF-α Antagonists

(2018) Sean M. McConachie et al.   ANNALS OF PHARMACOTHERAPY

Combining Biologics in Inflammatory Bowel Disease and Other Immune Mediated Inflammatory Disorders

(2018) Robert P. Hirten et al.   Clinical Gastroenterology and Hepatology

Meeting Report: AGA Biosimilars Roundtable

(2018) Colin W. Howden et al.   GASTROENTEROLOGY

Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases

(2018) Julien Kirchgesner et al.   GASTROENTEROLOGY

What Is the Risk of Progressive Multifocal Leukoencephalopathy in Patients With Ulcerative Colitis or Crohn’s Disease Treated With Vedolizumab?

(2018) Timothy Card et al.   INFLAMMATORY BOWEL DISEASES

P827 Prevalence of viral hepatitis in patients with IBD: A multi-centre and population-based study

(2018) E Badia et al.   Journal of Crohns & Colitis

DOP009 Comparative safety profile of vedolizumab and tumour necrosis factor–antagonist therapy for inflammatory bowel disease: a multicentre consortium propensity score-matched analysis

(2018) D Lukin et al.   Journal of Crohns & Colitis

Systematic Review and Meta-Analysis: Preoperative Vedolizumab Treatment and Postoperative Complications in Patients with Inflammatory Bowel Disease

(2018) Cindy C Y Law et al.   Journal of Crohns & Colitis

Serial Tuberculin Skin Tests Improves the Detection of Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease

(2018) Carlos Taxonera et al.   Journal of Crohns & Colitis

Management Strategies to Improve Outcomes of Patients With Inflammatory Bowel Diseases

(2017) Jean-Frederic Colombel et al.   GASTROENTEROLOGY

Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials

(2017) Julian Panés et al.   GUT

Long-term Efficacy, Safety, and Immunogenicity of Biosimilar Infliximab After One Year in a Prospective Nationwide Cohort

(2017) Lorant Gonczi et al.   INFLAMMATORY BOWEL DISEASES

Efficacy and Safety of Vedolizumab for Induction of Remission in Inflammatory Bowel Disease—the Israeli Real-World Experience

(2017) Uri Kopylov et al.   INFLAMMATORY BOWEL DISEASES

Serial Tuberculosis Screening in Inflammatory Bowel Disease Patients Receiving Anti-TNFα Therapy

(2017) Cândida Abreu et al.   Journal of Crohns & Colitis

P445 Perioperative use of vedolizumab seems not associated with short-term postoperative infectious complications in patients with Crohn's disease undergoing right hemicolectomy with ileocolonic anastomosis

(2017) N. Schils et al.   Journal of Crohns & Colitis

Herpes zoster in psoriasis patients treated with tofacitinib

(2017) Kevin L. Winthrop et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Successful treatment of chronic hepatitis C with ground ledipasvir/sofosbuvir in a patient with Crohn's disease and short bowel syndrome

(2017) J. von Felden et al.   JOURNAL OF VIRAL HEPATITIS

Crohn's disease

(2017) Joana Torres et al.   LANCET

Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial

(2017) Jean-Frederic Colombel et al.   LANCET

Ulcerative colitis

(2017) Ryan Ungaro et al.   LANCET

Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis

(2017) William J. Sandborn et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ustekinumab use in Crohn’s disease: a Canadian tertiary care centre experience

(2017) Astrid-Jane Greenup et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Immune response to hepatitis B vaccination among people with inflammatory bowel diseases: A systematic review and meta-analysis

(2017) Hai-yin Jiang et al.   VACCINE

The Safety and Immunogenicity of Live Zoster Vaccination in Patients With Rheumatoid Arthritis Before Starting Tofacitinib: A Randomized Phase II Trial

(2017) Kevin L. Winthrop et al.   Arthritis & Rheumatology

Vedolizumab induction therapy for inflammatory bowel disease in clinical practice - a nationwide consecutive German cohort study

(2016) D. C. Baumgart et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Postoperative Complications after Ileocecal Resection in Crohn’s Disease: A Prospective Study From the REMIND Group

(2016) Mathurin Fumery et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

The Real-World Effectiveness and Safety of Vedolizumab for Moderate–Severe Crohn’s Disease: Results From the US VICTORY Consortium

(2016) Parambir S Dulai et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Comparative Effectiveness and Safety of Anti–Tumor Necrosis Factor Agents in Biologic-Naive Patients With Crohn’s Disease

(2016) Siddharth Singh et al.   Clinical Gastroenterology and Hepatology

Biologic Therapies and Risk of Infection and Malignancy in Patients With Inflammatory Bowel Disease: A Systematic Review and Network Meta-analysis

(2016) Stefanos Bonovas et al.   Clinical Gastroenterology and Hepatology

Timing of Last Preoperative Dose of Infliximab Does Not Increase Postoperative Complications in Inflammatory Bowel Disease Patients

(2016) Anas Alsaleh et al.   DIGESTIVE DISEASES AND SCIENCES

Paradigm Shift in the Surveillance and Management of Dysplasia in Inflammatory Bowel Disease (West)

(2016) Roy Soetikno et al.   Digestive Endoscopy

The safety of vedolizumab for ulcerative colitis and Crohn's disease

(2016) Jean-Frédéric Colombel et al.   GUT

Patients with Refractory Crohnʼs Disease Successfully Treated with Ustekinumab

(2016) Kimberly A. Harris et al.   INFLAMMATORY BOWEL DISEASES

Management and Prevention of Herpes Zoster in the Immunocompromised Inflammatory Bowel Disease Patient

(2016) Justin Côté-Daigneault et al.   INFLAMMATORY BOWEL DISEASES

Immunogenicity of Influenza Vaccine for Patients with Inflammatory Bowel Disease on Maintenance Infliximab Therapy

(2016) Jennifer deBruyn et al.   INFLAMMATORY BOWEL DISEASES

Ustekinumab for the Treatment of Refractory Crohnʼs Disease

(2016) Sam Khorrami et al.   INFLAMMATORY BOWEL DISEASES

Postoperative Outcomes in Vedolizumab-Treated Patients Undergoing Abdominal Operations for Inflammatory Bowel Disease

(2016) Amy L. Lightner et al.   Journal of Crohns & Colitis

Negative Screening Does Not Rule Out the Risk of Tuberculosis in Patients with Inflammatory Bowel Disease Undergoing Anti-TNF Treatment: A Descriptive Study on the GETAID Cohort

(2016) Yael Abitbol et al.   Journal of Crohns & Colitis

Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease

(2016) Brian G. Feagan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Sofosbuvir, ledipasvir in IBD treated patients with advanced biologics including ribavirin eradicating chronic hepatitis C: SOLATAIRE C Trial. A multi-center clinical prospective pilot study

(2016) P.P. Basu et al.   HPB

Anal Neoplasia in Inflammatory Bowel Disease Is Associated With HPV and Perianal Disease

(2016) Joannie Ruel et al.   Clinical and Translational Gastroenterology

Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target

(2015) L Peyrin-Biroulet et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Impact of immunosuppressive therapy on hepatitis B vaccination in inflammatory bowel diseases

(2015) Arthur Belle et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Are Patients with Inflammatory Bowel Disease on Chronic Immunosuppressive Therapy at Increased Risk of Cervical High-grade Dysplasia/Cancer? A Meta-analysis

(2015) Jessica R. Allegretti et al.   INFLAMMATORY BOWEL DISEASES

Immunogenicity and Safety of Influenza Vaccine in Inflammatory Bowel Disease Patients Treated or not with Immunomodulators and/or Biologics: A Two-year Prospective Study

(2015) Odile Launay et al.   Journal of Crohns & Colitis

Booster influenza vaccination does not improve immune response in adult inflammatory bowel disease patients treated with immunosuppressives: a randomized controlled trial

(2015) Hiroko Matsumoto et al.   JOURNAL OF GASTROENTEROLOGY

Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults

(2015) Himal Lal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Post-marketing study of biosimilar infliximab (CT-P13) to evaluate its safety and efficacy in Korea

(2015) Sang Hyoung Park et al.   Expert Review of Gastroenterology & Hepatology

Biosimilar infliximab (CT-P13) in the treatment of inflammatory bowel disease: A Norwegian observational study

(2015) Jørgen Jahnsen et al.   Expert Review of Gastroenterology & Hepatology

A Phase 2 Study of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients With Crohn’s Disease

(2014) William J. Sandborn et al.   Clinical Gastroenterology and Hepatology

Subcutaneous ustekinumab for the treatment of anti-TNF resistant Crohn's disease—The McGill experience

(2014) U. Kopylov et al.   Journal of Crohns & Colitis

Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

(2014) J.F. Rahier et al.   Journal of Crohns & Colitis

Immunogenicity of hepatitis B vaccine in patients with inflammatory bowel disease and the benefits of revaccination

(2014) Yolima Cossio-Gil et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Infliximab Therapy in Pediatric Patients 7 Years of Age and Younger

(2014) Judith R. Kelsen et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) Study

(2013) John W Baddley et al.   ANNALS OF THE RHEUMATIC DISEASES

Increased risk of herpes zoster among 108 604 patients with inflammatory bowel disease

(2012) M. D. Long et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease

(2012) William J. Sandborn et al.   NEW ENGLAND JOURNAL OF MEDICINE

Incidence of HSV and HPV with azathioprine

(2009) Mario Cottone et al.   Nature Reviews Gastroenterology & Hepatology

Herpes Zoster with Skin Lesions and Meningitis Caused by 2 Different Genotypes of the Oka Varicella‐Zoster Virus Vaccine

(2008) Myron J. Levin et al.   JOURNAL OF INFECTIOUS DISEASES